Why BeiGene Soared 56.6% In July
After inking a collaboration agreement with biotech powerhouse Celgene (NASDAQ: CELG), shares in BeiGene Ltd. (NASDAQ: BGNE) rocketed 56.6% higher last month, according to S&P Global Market Intelligence.
Celgene loves locking up promising drugs in the pipeline of smaller peers, especially when those drugs could get to market relatively quickly.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Merck & Co. Inc. Stock
€104.60
-0.190%
The stock is one of the favorites of our community with 31 Buy predictions and 1 Sell predictions.
As a result the target price of 125 € shows a slightly positive potential of 19.5% compared to the current price of 104.6 € for Merck & Co. Inc..
